What is the relationship between the introduction of new clinical products and their respective economic impact? Clinical economic research compares clinical benefits and economic effects. This research aims to answer questions such as: Is there an economic savings with the introduction of this product, or will we encounter higher costs but a more optimal treatment. How would the current reimbursement system cover this product?
Depending on where your product is in its life cycle, it is very important to carry out the appropriate investigations in order to ensure that your product can successfully exist in the market.
The results of our research provide you with the necessary data to create the best strategy in introducing your product to the market.
In an early stage of the product life cycle, there is only limited or no actual patient data to evaluate (i.e. data provided by a physician’s daily routine documentation). The so-called economic model uses data from clinical trials to assess the economics. This raises the question: How much money can be saved by the hospital if the clinical process and outcome have been improved by the introduction of the new product/procedure.
In addition to the economic model, we offer registry studies from study design to study implementation. Registry studies belong to the so-called “non-interventional studies” and often focus on the question of whether the results of randomized clinical trials are transferable to the everyday treatment.
Real-World Data Analysis
At a later stage there are sometimes large amounts of actual patient data available. By analyzing this data, clinical and economic effects of a product/procedure can be determined more precisely.
Health Technology Assessment is becoming more and more important. The result of an HTA is usually published as an HTA report, which the Federal Joint Committee (G-BA) uses in its decision making process for health care policies. This includes the adoption of innovations into the catalog of statutory health insurance which is the precondition for reimbursement.
Health Services Research
Health services research examines the "reality" of medical care. It provides information on use, success and risks of diagnostic and therapeutic procedures as well as care concepts in everyday conditions.
Health services research is closely related with the analysis of the quality of care. Do certain therapies make it to the patients and if not, why not? Are specific drugs in everyday life as safe as in clinical trials or do unexpected side-effects occur when they are prescribed for patients who have other diseases or limitations that were not explicitly considered in the clinical trial?
We use actual patient data to evaluate this question for your product while it is in use.
Congress Contributions and Scientific Publications
The results of clinical-economic research have to be published in peer-reviewed journals. We will draft it and support you in both your publications and during the presentation at conferences.